Zhongke New Life has established three service platforms: scientific and technological services (protein/modification/metabolism research), biomedical characterization and confirmation, and precision medicine. Recently, hundreds of millions of yuan in Series B financing have been completed, led by Legend Capital, and Haoyue Capital served as the exclusive financial advisor for this round of financing. This round of financing will be used for the company’s deployment in the field of mass spectrometry multi-omics applications, innovative drug development and preclinical research and analysis, as well as accelerating product development, team building and market expansion, and making forward-looking layouts for precision medical services.
This article is reproduced from: https://www.itjuzi.com/investevent/13486218
This site is for inclusion only, and the copyright belongs to the original author.